When: Flush to $322-337 with stabilization (hammer candle, RSI<30, declining volume on flush)

Then: Deploy Tier 1 at $322-337 zone

When: Confirmed close >$375 (50 SMA) on volume >18M AND RSI>50

Then: Add Tier 2 at 35% of target

When: Flush to $322-337 with stabilization

Then: Add Tier 2 at 35% of target (better risk/reward)

When: Confirmed close >$400 with volume >25M AND 200 SMA reclaim with conviction

Then: Add Tier 3 at 35-40% of target

Wait for $322-$337 flush zone or confirmed close above 10 EMA at $353.78 before initiating Tranche 1

• MACD line at negative 6.26 signals momentum trying to bottom inside a broken trend, not a regime change
• ATR compressed from $18 to $10.76 does not indicate direction of next expansion
• PEG of 0.35 computed against TTM EPS of $7.83 artificially compressed by VMware intangible amortization; Forward P/E of 18 is realistic valuation
• Forward P/E of 18 against beta of 1.457 in rising rate environment with 97% implied odds of zero Fed cuts in 2026 is roughly in line with quality compounders, not 'exceptionally cheap'
• 97% Polymarket odds of no Fed cuts signal higher-for-longer discount rate environment harmful to AVGO's back-half-weighted $115 billion revenue trajectory
• China revenue mix dropped from 32% to 17%, but Beijing switch review shows Broadcom gear may be roughly 90% of installed equipment in state data centers—active, ongoing regulatory risk
• AVGO underperformance vs MRVL up 193% is recency bias to assume mean reversion without defined catalyst
• 21x peak price-to-sales at $1.67 trillion market cap against $80 billion peak revenue scenario is not obviously cheap for semiconductor with elevated risk
• Tranche 1 entry at $350 with $322 stop is 8% downside on 35% of target, risking approximately 2.8% of AI/semiconductor allocation
• Stock has lost its 50 SMA and is testing lower Bollinger Band in confirmed downtrend
• Primary technical support is single bullish divergence from September 16 that could resolve either direction
• Cost of being early is realized losses; cost of patience is opportunity cost only

→ vs aggressive: Bullish divergence from September 16 fails constantly in confirmed downtrends; it's a potential setup not a signal, and doesn't indicate whether $338 is the bottom or a pit stop en route to $308

→ vs aggressive: MACD histogram flip at negative 6.26 and ATR compression to $10.76 don't indicate direction; compressed volatility is as likely to precede a flush to $322 as an upside breakout

→ vs aggressive: PEG of 0.35 is intellectually dishonest—TTM EPS of $7.83 is artificially deflated by VMware amortization; Forward P/E of 18 is the realistic metric

→ vs aggressive: 97% Polymarket odds of no Fed cuts aren't 'priced in'—they signal genuine deterioration in liquidity environment with duration risk for AVGO's back-half-weighted cash flows

→ vs aggressive: China narrative isn't 'stale'—Beijing switch review shows Broadcom gear may be roughly 90% of installed equipment in state data centers; 17% remaining exposure can become 10%, 5% quickly if Beijing acts

→ vs aggressive: OpenAI pause is not 'noise'—hyperscaler pausing advanced model training is a leading indicator of demand hesitation with direct implications for custom silicon backlog

→ vs aggressive: MRVL up 193% vs AVGO flat YTD is recency bias to conclude AVGO is a coiled spring; the aggressive analyst identifies no catalyst for mean reversion

→ vs aggressive: 21x peak price-to-sales is not 'obviously cheap' for semiconductor company with high beta, geopolitical risk, and stretched $115 billion forecast

→ vs aggressive: Tranche structure is good risk management but entry at $350 is not conservative—it's deploying capital into confirmed downtrend with multiple hostile factors

→ vs aggressive: Aggressive analyst never answers what changes in 60 days making $330-$340 unavailable; missing a move is not the same as losing capital

BUY with modified tranche plan: reduce Tranche 1 to 25-30%, tighten entry criteria to require either reclaim of 10 EMA at $353.78 on volume or flush to $322-337 zone with stabilization, add Q4 2027 earnings decision framework, add macro invalidation trigger if 10-year Treasury breaks range or VIX above 35.

• Fundamentals exceptional: 54% operating margin, $30.6B TTM FCF, 85% YoY revenue growth
• Market cap grew from ~$850B to $1.67T over three years
• Technical exhaustion signals present: bullish RSI divergence, MACD histogram flip in negative territory, ATR compression
• MACD line still at negative 6.26, indicating momentum twitch not regime change
• Forward PE of 18 more accurate than PEG of 0.35 (which is artificially depressed by VMware amortization)
• China risk is real but bounded: 17% revenue down from 32%, 90% installed base in state data centers
• 97% Polymarket odds of no Fed cuts is a real headwind for long-duration growth
• Aggressive analyst correct on fundamentals but treats technical divergence as confirmed bottom rather than possibility
• Conservative analyst correct on forward PE and macro headwinds but overstates China risk and underweights opportunity cost
• Q4 2027 earnings is key validation point: beat-and-raise triggers Tranche 2 addition, meet-but-no-raise holds, miss cuts Tranche 1 entirely
• Macro invalidation triggers: halt Tranche 2 and 3 deployment if 10-year Treasury breaks range or VIX above 35
• Tightened entry criteria: require either reclaim of 10 EMA at $353.78 on volume OR flush to $322-337 zone with stabilization signals
• Marvell comparison: more likely MRVL gives back gains while AVGO holds—different businesses, gap reflects fundamentals
• Current price zone $345-355 is worst of both worlds, capturing neither better entry nor immediate momentum

→ vs aggressive: Treats technical divergence as confirmed bottom when it's a possibility; bullish divergences in downtrends fail more often than they succeed, especially with macro headwinds

→ vs aggressive: Six-to-one reward-to-risk framing is theoretical—risking 8% to capture 50% only works if stock holds $322; in beta 1.457 stock, flush could easily extend to $308 or lower

→ vs aggressive: China risk argument is backwards: concentrated remaining exposure of 17% is MORE vulnerable to regulatory action, not less; Beijing could reduce 17% to 10% quickly

→ vs aggressive: OpenAI pause dismissed too quickly—it might be operational efficiency or it might signal hyperscalers questioning AI capex buildout pace; uncertainty warrants caution

→ vs conservative: Treats patience as free when it isn't—missing $20-30 entry on $500 stock over 18 months means material total return sacrifice

→ vs conservative: Addresses opportunity cost in exactly one sentence then dismisses it, which is intellectually lazy

→ vs conservative: Overstates China risk—17% of revenue is meaningful but not dominant driver; 90% installed base is being gradually reduced, not eliminated

→ vs conservative: OpenAI pause as 'first crack in AI capex super-cycle' is hypothesis not fact

→ vs conservative: Entire framework essentially 'don't take any risk until you have certainty'—recipe for underperforming in any market, particularly problematic for secular tailwind names like AVGO